(19)
(11) EP 2 493 918 A2

(12)

(88) Date of publication A3:
25.08.2011

(43) Date of publication:
05.09.2012 Bulletin 2012/36

(21) Application number: 10827453.1

(22) Date of filing: 28.10.2010
(51) International Patent Classification (IPC): 
C07K 14/47(2006.01)
A61P 25/00(2006.01)
A61K 38/17(2006.01)
(86) International application number:
PCT/US2010/054419
(87) International publication number:
WO 2011/053675 (05.05.2011 Gazette 2011/18)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 30.10.2009 US 256352 P

(71) Applicants:
  • CNS Therapeutics, Inc.
    Woodbury, MN 55125 (US)
  • University Of Helsinki
    00014 University Of Helsinki (FI)

(72) Inventors:
  • RUNEBERG-ROOS, Pia
    Woodbury, MN 55125 (US)
  • BESPALOV, Maxim
    Woodbury, MN 55125 (US)
  • PENN, Richard
    Woodbury, MN 55125 (US)
  • SAARMA, Mart
    Woodbury, MN 55125 (US)

(74) Representative: Rutt, Jason Edward 
Rouse Patents Patents Agency 11th Floor, Exchange Tower 1 Harbour Exchange Square
London E14 9GE
London E14 9GE (GB)

   


(54) IMPROVED NEURTURIN MOLECULES